文献速递肝病消化道肿瘤与早癌

钙结合蛋白39通过激活细胞外信号调节激酶信号通路促进肝细胞癌生长和转移

Calcium-binding protein 39 promotes hepatocellular carcinoma growth and metastasis by activating extracellular signal-regulated kinase signaling pathway.
PubMed 文献 · Hepatology · 2017-09-29

该研究报道钙结合蛋白39(CAB39)在肝细胞癌中频繁上调,且与肿瘤转移(P=0.000)、较差的无病生存率(P=0.027)和不良预后(P=0.000)显著相关。在LO2、QGY-7703和BEL-7402细胞中过表达CAB39可增加病灶形成、软琼脂集落形成、裸鼠成瘤和细胞运动;在Huh7和MHCC97H细胞中用短发夹RNA沉默CAB39可有效消除其致癌功能。CAB39通过激活细胞外信号调节激酶(ERK)通路并促进上皮-间质转化发挥作用,作者认为其可能作为预后预测的生物标志物和新的治疗靶点。

要点

  • CAB39在肝细胞癌中频繁上调,与肿瘤转移(P=0.000)、较差的无病生存率(P=0.027)和不良预后(P=0.000)显著相关。
  • 过表达CAB39可增加LO2、QGY-7703和BEL-7402细胞的病灶形成、软琼脂集落形成、裸鼠成瘤和细胞运动。
  • 沉默CAB39可消除Huh7和MHCC97H细胞的致癌功能,其作用与激活ERK通路和促进上皮-间质转化相关。

核心结论

  • CAB39通过激活ERK信号通路在肝细胞癌发病和进展中发挥重要致癌作用,作者认为其可能作为预后预测的生物标志物和新的治疗靶点。

研究设计与样本

  • 研究采用细胞实验(LO2、QGY-7703、BEL-7402、Huh7、MHCC97H细胞系)和裸鼠成瘤实验,结合肝细胞癌组织标本分析CAB39表达与临床预后的关系。

主要发现

  • CAB39在肝细胞癌中频繁上调,与肿瘤转移(P=0.000)、较差的无病生存率(P=0.027)和不良预后(P=0.000)显著相关。
  • 在LO2、QGY-7703和BEL-7402细胞中过表达CAB39可增加病灶形成、软琼脂集落形成、裸鼠成瘤和细胞运动。
  • 在Huh7和MHCC97H细胞中用短发夹RNA沉默CAB39可有效消除其致癌功能。
  • CAB39促进ERK通路激活,其关键位点突变可显著降低磷酸化ERK水平。
  • CAB39通过上调N-钙黏蛋白和纤连蛋白、下调E-钙黏蛋白和α-E-连环蛋白促进上皮-间质转化,并增加β-连环蛋白核转位和上调基质金属蛋白酶-9。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Calcium-binding protein (CAB39) is a key regulator of a group of sterile 20 kinases. Here, we report that CAB39 was frequently up-regulated in hepatocellular carcinoma (HCC), which was significantly associated with tumor metastasis (P = 0.000), poorer disease-free survival rate (P = 0.027), and poor prognosis (P = 0.000). Ectopic expression of CAB39 in immortalized human liver cell line LO2 and HCC cell lines QGY-7703 and BEL-7402 could increase foci formation, colony formation in soft agar, tumor formation in nude mice, and cell motility. Silencing CAB39 expression in two HCC cell lines, Huh7 and MHCC97H, with short hairpin RNA could effectively abolish its oncogenic function. Further study found that CAB39 contributed to extracellular signal-regulated kinase (ERK) pathway activation, and mutations of the key sites of CAB39 markedly decrease the level of phosphorylated ERK. In addition, CAB39 could promote epithelial-mesenchymal transition by up-regulating N-cadherin and Fibronectin and down-regulating E-cadherin and α-E-catenin. As a result, β-catenin nuclear translocation was increased and its downstream target gene, matrix metalloproteinase-9, was up-regulated. CONCLUSION: Taken together, our findings suggested that CAB39 played very important oncogenic roles in HCC pathogenesis and progression by activating the ERK signaling pathway. Better understanding of CAB39 may lead to its clinical application as a biomarker for a prognosis predictor and a novel therapeutic target. (Hepatology 2017;66:1529-1545).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Jiang L, Yan Q, Fang S, et al. Calcium-binding protein 39 promotes hepatocellular carcinoma growth and metastasis by activating extracellular signal-regulated kinase signaling pathway. Hepatology. 2017. PMID: 28605041. doi:10.1002/hep.29312

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。